Chugai Pharmaceutical Co
Chugai Pharmaceutical Co., Ltd., commonly referred to as Chugai Pharma, is a leading Japanese pharmaceutical preparation manufacturer headquartered in Japan. Established in 1925, the company has a long-standing history of innovation within the pharmaceutical industry, with a focus on developing advanced biopharmaceuticals and specialty medicines. Its core operations span Japan and key international markets, where it is recognised for its commitment to improving patient outcomes through cutting-edge research and development.
Specialising in areas such as oncology, immunology, and rare diseases, Chugai distinguishes itself through its robust pipeline of innovative therapies and strategic collaborations. As a prominent player in the pharmaceutical manufacturing sector, the company has earned a reputation for high-quality products and significant contributions to medical science, maintaining a strong market position both domestically and globally.
+10 vs industry average
Chugai Pharmaceutical Co’s score of 49 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Chugai Pharmaceutical Co?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Chugai Pharmaceutical Co's reported carbon emissions
Chugai Pharmaceutical Co., a Japanese pharmaceutical preparation manufacturing company, is committed to achieving net-zero emissions by 2050, covering both Scope 1 and Scope 2 emissions.
For emissions data, Chugai Pharmaceutical Co. reported the following:
- 2025: Scope 1 and 2 emissions totalled approximately 49.9 million kg CO2e. Scope 3 emissions were approximately 980.5 million kg CO2e.
- 2024: Scope 1 and 2 emissions were approximately 53.9 million kg CO2e, with Scope 3 emissions at about 1.14 billion kg CO2e.
- 2023: Scope 1 and 2 emissions were approximately 50.8 million kg CO2e, and Scope 3 emissions were around 1.10 billion kg CO2e.
- 2022: Scope 1 emissions were approximately 49.4 million kg CO2e, and Scope 2 emissions were about 11.9 million kg CO2e. Total Scope 3 emissions were approximately 2.23 billion kg CO2e.
- 2021: Scope 1 emissions were approximately 47 million kg CO2e, and Scope 2 emissions totalled about 20.8 million kg CO2e. Scope 3 data was not disclosed for this year.
- 2020: Scope 1 emissions were approximately 41.7 million kg CO2e, and Scope 2 emissions were about 62.1 million kg CO2e. Scope 3 data was not disclosed for this year.
- 2019: Scope 1 emissions were approximately 47.3 million kg CO2e, and Scope 2 emissions were around 65.5 million kg CO2e. Scope 3 data was not disclosed for this year.
- 2018: Scope 1 emissions were approximately 49.5 million kg CO2e, Scope 2 emissions were about 62.1 million kg CO2e, and Scope 3 emissions were approximately 4.6 million kg CO2e.
Chugai Pharmaceutical Co. has set Science Based Targets initiative (SBTi) commitments, which are cascaded from the ultimate parent company through its corporate family relationship. Notably, they commit to reducing absolute Scope 1 and 2 GHG emissions by 60% by 2030 from a 2019 base year. Furthermore, they aim to increase their sourcing of renewable electricity to 100% by 2025 and commit to reducing absolute Scope 3 GHG emissions by 30% by 2030 from a 2019 base year. There are also SBTi commitments from "Chug, Inc." and "Chugai Co., Ltd." indicating a broader group-level approach to emissions reduction.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Chugai Pharmaceutical Co’s Climate Goals (2030 & 2050)
2 goals2030
42% reduction in Scope 2
2030
42% reduction in Scope 1
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Chugai Pharmaceutical Co
Frequently asked questions
Common questions about Chugai Pharmaceutical Co’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project